Department of Food Science and Technology, University of Nebraska, Lincoln, Nebraska, USA.
Department of Food Science, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Appl Environ Microbiol. 2019 Oct 30;85(22). doi: 10.1128/AEM.01788-19. Print 2019 Nov 15.
Strains of are commonly used as probiotics due to their demonstrated therapeutic properties. Many strains of also utilize the prebiotic galactooligosaccharide (GOS), providing a basis for formulating synergistic synbiotics that could enhance growth or persistence of this organism In this study, in-frame deletion mutants were constructed to characterize the molecular basis of GOS utilization in ATCC PTA-6475. Results suggested that GOS transport relies on a permease encoded by , while a second unidentified protein may function as a galactoside transporter. Two β-galactosidases, encoded by and , sequentially degrade GOS oligosaccharides and GOS disaccharides, respectively. Inactivation of and resulted in impaired growth in the presence of GOS and lactose. competition experiments between the wild-type and strains revealed that the GOS-utilizing genes conferred a selective advantage in media with GOS but not glucose. GOS also provided an advantage to the wild-type strain in experiments in gnotobiotic mice but only on a purified, no sucrose diet. Differences in cell numbers between GOS-fed mice and mice that did not receive GOS were small, suggesting that carbohydrates other than GOS were sufficient to support growth. On a complex diet, the strain was outcompeted by the wild-type strain in gnotobiotic mice, suggesting that and are involved in the utilization of alternative dietary carbohydrates. Indeed, the growth of the mutants was impaired in raffinose and stachyose, which are common in plants, demonstrating that α-galactosides may constitute alternate substrates of the GOS pathway. This study shows that genes in encode hydrolases and transporters that are necessary for the metabolism of GOS, as well as α-galactoside substrates. Coculture experiments with the wild-type strain and a mutant clearly demonstrated that GOS utilization confers a growth advantage in medium containing GOS as the sole carbohydrate source. However, the wild-type strain also outcompeted the mutant in germfree mice, suggesting that GOS genes in also provide a basis for utilization of other carbohydrates, including α-galactosides, ordinarily present in the diets of humans and other animals. Collectively, our work provides information on the metabolism of in its natural niche in the gut and may provide a basis for the development of synbiotic strategies.
由于其治疗特性,被广泛用作益生菌。许多也利用了益生元半乳糖寡糖(GOS),这为制定协同共生体提供了基础,共生体可以增强该生物体的生长或持久性。在这项研究中,构建了框内缺失突变体,以表征 ATCC PTA-6475 中 GOS 利用的分子基础。结果表明,GOS 运输依赖于由编码的渗透酶,而第二个未识别的蛋白质可能作为半乳糖苷转运蛋白发挥作用。两种β-半乳糖苷酶,分别由编码和,依次降解 GOS 低聚糖和 GOS 二糖。失活和导致在存在 GOS 和乳糖时生长受损。野生型和菌株之间的竞争实验表明,GOS 利用基因在含有 GOS 但不含葡萄糖的培养基中赋予了选择性优势。GOS 也为野生型菌株在无菌小鼠中的实验提供了优势,但仅在纯化的、不含蔗糖的饮食中。GOS 喂养的小鼠和未接受 GOS 的小鼠之间的细胞数量差异很小,表明除 GOS 以外的碳水化合物足以支持生长。在复杂的饮食中,在无菌小鼠中,菌株被野生型菌株竞争淘汰,表明和参与了替代膳食碳水化合物的利用。事实上,突变体的生长在棉子糖和水苏糖中受到损害,棉子糖和水苏糖是植物中常见的物质,表明α-半乳糖苷可能构成 GOS 途径的替代底物。这项研究表明,编码水解酶和转运蛋白,这些酶和蛋白对于 GOS 的代谢以及α-半乳糖苷底物是必需的。与野生型菌株和突变体的共培养实验清楚地表明,在仅含有 GOS 作为唯一碳源的培养基中,GOS 的利用赋予了生长优势。然而,野生型菌株在无菌小鼠中也竞争淘汰了突变体,表明中的 GOS 基因也为利用其他碳水化合物提供了基础,包括通常存在于人类和其他动物饮食中的α-半乳糖苷。总的来说,我们的工作提供了关于在肠道其自然生态位中代谢的信息,并且可能为共生体策略的发展提供了基础。